methyl 2-methyl-4-(3-nitrophenyl)-5-oxo-7H-furo[3,4-b]pyridine-3-carboxylate structure
|
Common Name | methyl 2-methyl-4-(3-nitrophenyl)-5-oxo-7H-furo[3,4-b]pyridine-3-carboxylate | ||
---|---|---|---|---|
CAS Number | 64603-74-3 | Molecular Weight | 328.27600 | |
Density | 1.423g/cm3 | Boiling Point | 582.9ºC at 760mmHg | |
Molecular Formula | C16H12N2O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 306.3ºC |
Name | methyl 2-methyl-4-(3-nitrophenyl)-5-oxo-7H-furo[3,4-b]pyridine-3-carboxylate |
---|---|
Synonym | More Synonyms |
Density | 1.423g/cm3 |
---|---|
Boiling Point | 582.9ºC at 760mmHg |
Molecular Formula | C16H12N2O6 |
Molecular Weight | 328.27600 |
Flash Point | 306.3ºC |
Exact Mass | 328.07000 |
PSA | 111.31000 |
LogP | 2.94540 |
Index of Refraction | 1.623 |
~97% methyl 2-methyl... CAS#:64603-74-3 |
Literature: Goerlitzer; Bartke Pharmazie, 2002 , vol. 57, # 10 p. 672 - 678 |
~% methyl 2-methyl... CAS#:64603-74-3 |
Literature: Goerlitzer; Bartke Pharmazie, 2002 , vol. 57, # 10 p. 672 - 678 |
~% methyl 2-methyl... CAS#:64603-74-3 |
Literature: Lehmann; Kahlich; Meyer zum Gottesberge; Fricke Archiv der Pharmazie, 1997 , vol. 330, # 8 p. 247 - 252 |
~% methyl 2-methyl... CAS#:64603-74-3 |
Literature: Shibanuma; Iwanami; Fujimoto; et al. Chemical and Pharmaceutical Bulletin, 1980 , vol. 28, # 9 p. 2609 - 2613 |
~% methyl 2-methyl... CAS#:64603-74-3 |
Literature: Shibanuma; Iwanami; Fujimoto; et al. Chemical and Pharmaceutical Bulletin, 1980 , vol. 28, # 9 p. 2609 - 2613 |
~% methyl 2-methyl... CAS#:64603-74-3 |
Literature: Shibanuma; Iwanami; Fujimoto; et al. Chemical and Pharmaceutical Bulletin, 1980 , vol. 28, # 9 p. 2609 - 2613 |
~% methyl 2-methyl... CAS#:64603-74-3 |
Literature: Meyer; Scherling; Karl Arzneimittel-Forschung/Drug Research, 1983 , vol. 33, # 11 p. 1528 - 1534 |
~% methyl 2-methyl... CAS#:64603-74-3 |
Literature: Shibanuma; Iwanami; Fujimoto; et al. Chemical and Pharmaceutical Bulletin, 1980 , vol. 28, # 9 p. 2609 - 2613 |
~% methyl 2-methyl... CAS#:64603-74-3
Detail
|
Literature: Scherling; Karl; Ahr; Kern; Siefert Arzneimittel-Forschung/Drug Research, 1991 , vol. 41, # 10 p. 1009 - 1021 |
BAY-m 4797 |